Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Accounts Payables (2016 - 2025)

Mimedx (MDXG) has disclosed Accounts Payables for 15 consecutive years, with $14.5 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 96.09% to $14.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.5 million through Dec 2025, up 96.09% year-over-year, with the annual reading at $14.5 million for FY2025, 96.09% up from the prior year.
  • Accounts Payables hit $14.5 million in Q4 2025 for Mimedx, up from $11.4 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $14.5 million in Q4 2025 to a low of $6.9 million in Q3 2021.
  • Historically, Accounts Payables has averaged $8.7 million across 5 years, with a median of $8.3 million in 2022.
  • Biggest five-year swings in Accounts Payables: dropped 29.02% in 2021 and later skyrocketed 96.09% in 2025.
  • Year by year, Accounts Payables stood at $7.4 million in 2021, then rose by 14.48% to $8.5 million in 2022, then increased by 7.03% to $9.0 million in 2023, then decreased by 18.11% to $7.4 million in 2024, then surged by 96.09% to $14.5 million in 2025.
  • Business Quant data shows Accounts Payables for MDXG at $14.5 million in Q4 2025, $11.4 million in Q3 2025, and $8.5 million in Q2 2025.